
BACKGROUND: Clozapine is the only licensed medication with established efficacy for treatment-resistant schizophrenia (TRS), yet it remains underutilised internationally. Delayed initiation is associated with poorer clinical outcomes, and clinician-related factors contribute to underuse. Limited research has examined trainee psychiatrists' knowledge and experience of clozapine prescribing. METHODS: A cross-sectional online survey was distributed via the College of Psychiatrists of Ireland to approximately 500 psychiatry trainees between June 2024 and January 2025. The questionnaire assessed clinical experience, knowledge, confidence in clozapine management and perceived barriers to initiation. RESULTS: Seventy-four trainee psychiatrists completed the survey (response rate 14.8%). Most respondents had clinical exposure to clozapine; but fewer than one-third reported receiving specific clinical training. Knowledge regarding the indication for clozapine in TRS was strong, while knowledge relating to therapeutic drug monitoring, dosing and agranulocytosis risk was more variable. Respondents reported positive attitudes towards clozapine's effectiveness and safety. Confidence was highest in identifying TRS and monitoring mental health during treatment, but was lower for physical health monitoring, managing adverse-effects, discontinuation and rechallenge. Perceived barriers included concerns regarding adherence, blood monitoring requirements, adverse effects, and delays associated with hospital admission. Most respondents reported insufficient training in clozapine prescribing. CONCLUSIONS: Respondents reported positive perceptions of clozapine and good knowledge of its indication for TRS, although practical prescribing knowledge appeared more variable. Most reported limited formal training and low confidence in several practical aspects of clozapine management. Structured clozapine education and supervised clinical experience may improve trainee confidence and preparedness for clozapine prescribing.
Abstract Objectives: People bereaved by suicide can experience emotional and psychological burdens when engaging with institutional processes such as coronial inquests. This qualitative study examines the experiences of suicide-bereaved individuals in Ireland who have navigated the inquest system. Methods: The research utilises secondary data drawn from the Irish Suicide Bereavement Survey, a national survey that explored the experiences and support needs of individuals bereaved by suicide in Ireland. Data were obtained on a sub-sample of participants ( n = 735) who reported having gone through the coronial inquest process as a result of suicide bereavement. Reflexive thematic analysis was used to examine participants’ responses to inquest-related questions. Results: Four main themes shaped participants’ experiences of the inquest process: availability and adequacy of support, communication and information provision, privacy considerations, and impact of delays and prolonged timelines. Many reported challenges related to limited support and unclear communication, which for some contributed to feelings of distress and uncertainty. Privacy concerns, particularly regarding public court settings and media involvement, were also commonly noted. Additionally, prolonged wait times were reported as a source of emotional strain for some individuals. Conclusion: The findings suggest that changes to certain aspects of the inquest, such as privacy and stronger support systems, could make the inquest process easier for people who have experienced a loss through suicide. Further research could look at how specific types of support or targeted interventions could help those affected by suicide bereavement within the legal framework of inquests.
Abstract Sexual violence is common in Ireland and can have important psychological and psychiatric consequences. This paper examines sexual assault in Ireland, the role of Sexual Assault Treatment Units (SATUs), evidence on mental health outcomes following sexual violence, and current psychological and psychiatric supports. Ireland has a mature national SATU network providing acute medical and forensic care, with links to Rape Crisis Centres (RCCs), Sexual Violence Centres (SVCs), and other supports. However, sexual assault is also a potentially life-altering psychological trauma, associated with post-traumatic stress disorder (PTSD), depression, anxiety, suicidality, substance misuse, and deterioration in pre-existing mental illness. We argue that care should be understood as a coordinated, trauma-informed pathway. We propose brief early psychological intervention at first SATU contact, better funding for allied support services, and an integrated national pathway for continuing trauma-informed psychological and psychiatric care.
Abstract Objectives: Psychiatric inpatient care is a high-resource component of mental health systems. Understanding the diagnoses driving inpatient care is essential for evidence-based service planning. This study describes psychiatric inpatient bed use in Ireland from 2013 to 2023 by diagnosis, sex, and age group. Methods: National descriptive analyses using aggregated data from the National Psychiatric Inpatient Reporting System, covering acute inpatient admissions in Ireland. The outcome was total number of inpatient bed days, categorised by ICD-10 diagnostic group. Primary analyses focused on public services, with private services reported separately. We additionally report on child and adolescent mental health services (CAMHS), adult services, and sex-stratified results. Results: Between 2013 and 2023, there were k=3,993,628 public and k=1,879,877 private inpatient bed days. In public services, schizophrenia spectrum disorders accounted for 41.9% of bed days (k=1,673,529), more than twice as many as the next most prevalent diagnosis. Men accounted for 51.2% of acute public bed days. In private adult services, depressive disorders accounted for the largest proportion of bed days (28.5%, k=513,166). In public and private CAMHS, eating disorders accounted for the largest proportion of bed days (25.6%, k=46,850 and 24.4%, k=18,775), respectively. Conclusion: This national analysis demonstrates that schizophrenia spectrum disorders represent, by far, the largest diagnostic group, accounting for 42% of public acute psychiatric inpatient beds days, highlighting the sustained, intensive service demands associated with these disorders. These data provide a clear empirical basis for future service planning, highlighting where targeted enhancements to community-based care could most effectively reduce the need for hospitalisation.